EcoDrugPlus

Cathepsin S

Ensembl ID : ENSSFOG00015011906
Gene Symbol: CTSS
3 Cross references
234 Possible Orthologues:

Cathepsin S-Like

Ensembl ID : ENSSFOG00015011929
Gene Symbol: LOC108941877
2 Cross references
234 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSSFOG00015020185
Gene Symbol: CDC7
3 Cross references
208 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSSFOG00015006236
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSSFOG00015017747
Gene Symbol: CHEK2
1 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSSFOG00015033093
Gene Symbol: CCKAR
3 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSSFOG00015023073
Gene Symbol: CCKBR
1 Cross references
262 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSSFOG00015011493
Gene Symbol: CCKBR
1 Cross references
262 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSSFOG00015032361
Gene Symbol: LOC114912328
2 Cross references
256 Possible Orthologues:

Cholesterol 24-Hydroxylase-Like

Ensembl ID : ENSSFOG00015031610
Gene Symbol: LOC114912329
2 Cross references
256 Possible Orthologues:

Cholesteryl Ester Transfer Protein, Plasma

Ensembl ID : ENSSFOG00015013540
Gene Symbol: CETP
1 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 1

Ensembl ID : ENSSFOG00015029971
Gene Symbol: CHRM1
1 Cross references
101 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).